NCT00517465View on ClinicalTrials.gov

A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus.

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Diabetes Mellitus Type 2
Interventions
DRUG

Placebo

po bid

DRUG

RG1511

Starting multiple doses of 100mg po bid escalated in subsequent groups of patients to potential maximum multiple dose of 1200mg po bid.

Trial Locations (8)

1027

Budapest

8230

Balatonfüred

14050

Berlin

41460

Neuss

82108

Bratislava

833 05

Bratislava

SL1 4AA

Slough

AL7 1TW

Welwyn Garden City

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00517465 - A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus. | Biotech Hunter | Biotech Hunter